- ICH GCP
- Register voor klinische proeven in de VS.
- Klinische proef NCT07798063
Effectiveness of Solution-Focused Therapy for Generalized Anxiety Disorder in Emerging Adults
Studie Overzicht
Toestand
Conditie
Interventie / Behandeling
Gedetailleerde beschrijving
Anxiety disorders are common worldwide, and anxiety and stress symptoms are particularly prevalent among university students in Pakistan. Emerging adulthood is a critical developmental period characterized by significant transitions, identity exploration, and heightened stress, during which Generalized Anxiety Disorder (GAD) can emerge. GAD is characterized by excessive and persistent anxiety and worry related to different areas of life, including work, family, health, or finances. Although conventional psychological therapies are available for such mental health problems, they can be time-consuming and costly. Therefore, shorter and effective psychological interventions are needed. Solution-Focused Therapy (SFT) has been supported by research as an approach in which fewer sessions may be sufficient for improving psychological symptoms. However, there is limited literature on the effectiveness of SFT for emerging adults with anxiety disorders in Pakistan, and the intervention has not been culturally validated for Pakistani emerging adults with GAD.
This study aims to examine the effectiveness of Solution-Focused Therapy for Generalized Anxiety Disorder in emerging adults in Pakistan. The study will use a randomized controlled trial design. Emerging adults aged 18-29 years will first be screened using the Generalized Anxiety Disorder 7-item (GAD-7) Scale to identify participants with mild to moderate levels of GAD. Eligible participants will then be randomly assigned to a treatment group receiving SFT or a waitlist control group. The SFT intervention will be applied to participants with GAD to examine its effectiveness in reducing their anxiety symptoms.
The study will assess changes in GAD symptoms before and after the intervention to determine the effectiveness of SFT among emerging adults with GAD in Pakistan. It is expected that participants receiving SFT will show a decline in GAD symptoms compared with the waitlist control group. The study will provide evidence regarding the effectiveness of a brief and culturally relevant SFT intervention for emerging adults with GAD in the Pakistani context.
Studietype
Inschrijving (Geschat)
Fase
- Niet toepasbaar
Contacten en locaties
Studiecontact
- Naam: Fariha Hayat, MS
- Telefoonnummer: +92 3365288229
- E-mail: fariha.hayat87@gmail.com
Studie Locaties
-
-
-
Islamabad, Pakistan, 44000
- Werving
- International Islamic University Islamabad (IIUI)
-
Contact:
- Dr Nazia Iqbal, Post-doc
- Telefoonnummer: +92-51-9019338
- E-mail: nazia.iqbal@iiu.edu.pk
-
-
Deelname Criteria
Geschiktheidscriteria
Leeftijden die in aanmerking komen voor studie
- Volwassen
Accepteert gezonde vrijwilligers
Beschrijving
Inclusion Criteria: Participants with mild to moderate scores of generalized anxiety disorder upon baseline assessment will be included in the study.
Exclusion Criteria: Individuals will be excluded if they reported a diagnosis of psychotic disorder, and those receiving psychotherapy or counseling for anxiety.
Studie plan
Hoe is de studie opgezet?
Ontwerpdetails
- Primair doel: Behandeling
- Toewijzing: Gerandomiseerd
- Interventioneel model: Parallelle opdracht
- Masker: Geen (open label)
Wapens en interventies
Deelnemersgroep / Arm |
Interventie / Behandeling |
|---|---|
|
Experimenteel: Intervention Group (Receiving Solution-Focused Therapy)
Participants in the intervention group will receive Solution-Focused Therapy (SFT) for mild to moderate Generalized Anxiety Disorder.
|
Participants in intervention group will receive Solution-Focused Therapy.
The program includes approximately 6-8 individual sessions (45-60 minutes) covering goal-setting, exception-finding, scaling questions, the miracle question, identification of existing strengths and resources, and construction of solution-focused action steps.
|
|
Geen tussenkomst: Control Group (Waitlist Control Group)
Participants in the control group will not receive Solution-Focused Brief Therapy during the active trial period and will instead be assigned to a waitlist condition.
|
Wat meet het onderzoek?
Primaire uitkomstmaten
Uitkomstmaat |
Maatregel Beschrijving |
Tijdsspanne |
|---|---|---|
|
Generalized Anxiety Disorder 7-item (GAD-7)
Tijdsspanne: Baseline and Week 8
|
The Generalized Anxiety Disorder 7-item (GAD-7) scale assesses severity of anxiety symptoms.
Total scores range from 0 to 21.
Higher scores indicate more severe anxiety symptoms.
|
Baseline and Week 8
|
|
Depression Anxiety Stress Scales - Short Form (DASS-21)
Tijdsspanne: Baseline and Week 8
|
The Depression Anxiety Stress Scales - Short Form (DASS-21) measures emotional distress.
The total score ranges from 0 to 63 (combining depression, anxiety, and stress subscales).
Higher scores indicate more severe emotional distress.
|
Baseline and Week 8
|
Secundaire uitkomstmaten
Uitkomstmaat |
Maatregel Beschrijving |
Tijdsspanne |
|---|---|---|
|
Intolerance of Uncertainty Scale - Short Form (IUS-12)
Tijdsspanne: Baseline and Week 8
|
The Intolerance of Uncertainty Scale - Short Form assesses reactions to ambiguous situations.
Total scores range from 12 to 60. Higher scores indicate a greater intolerance of uncertainty.
|
Baseline and Week 8
|
|
Negative Problem Orientation Questionnaire (NPOQ)
Tijdsspanne: Baseline and Week 8
|
The Negative Problem Orientation Questionnaire (NPOQ) evaluates dysfunctional cognitive attitudes toward problem-solving.
Total scores range from 12 to 60. Higher scores indicate a more negative problem orientation.
|
Baseline and Week 8
|
|
Difficulties in Emotion Regulation Scale - Short Form (DERS-SF)
Tijdsspanne: Baseline and Week 8
|
The Difficulties in Emotion Regulation Scale - Short Form (DERS-SF) assesses emotion dysregulation.
Total scores range from 18 to 90.
Higher scores indicate greater difficulty in regulating emotions.
|
Baseline and Week 8
|
|
Brief Resilience Scale
Tijdsspanne: Baseline and Week 8
|
The Brief Resilience Scale (BRS) measures the ability to recover from stress.
Total scores range from 6 to 30.
Higher scores indicate greater resilience (a better outcome).
|
Baseline and Week 8
|
Medewerkers en onderzoekers
Onderzoekers
- Hoofdonderzoeker: Fariha Hayat, MS, International Islamic University, Islamabad
Studie record data
Bestudeer belangrijke data
Studie start (Werkelijk)
Primaire voltooiing (Geschat)
Studie voltooiing (Geschat)
Studieregistratiedata
Eerst ingediend
Eerst ingediend dat voldeed aan de QC-criteria
Eerst geplaatst (Werkelijk)
Updates van studierecords
Laatste update geplaatst (Werkelijk)
Laatste update ingediend die voldeed aan QC-criteria
Laatst geverifieerd
Meer informatie
Termen gerelateerd aan deze studie
Aanvullende relevante MeSH-voorwaarden
Andere studie-ID-nummers
- IIUI/ORIC/Bioethics/110-1928
Plan Individuele Deelnemersgegevens (IPD)
Bent u van plan om gegevens van individuele deelnemers (IPD) te delen?
Informatie over medicijnen en apparaten, studiedocumenten
Bestudeert een door de Amerikaanse FDA gereguleerd geneesmiddel
Bestudeert een door de Amerikaanse FDA gereguleerd apparaatproduct
Deze informatie is zonder wijzigingen rechtstreeks van de website clinicaltrials.gov gehaald. Als u verzoeken heeft om uw onderzoeksgegevens te wijzigen, te verwijderen of bij te werken, neem dan contact op met register@clinicaltrials.gov. Zodra er een wijziging wordt doorgevoerd op clinicaltrials.gov, wordt deze ook automatisch bijgewerkt op onze website .